Acute Transverse Myelitis in a Patient with Rheumatoid Arthritis Treated with Intravenous Immunoglobulin.
10.3904/kjm.2015.89.5.604
- Author:
Bo Ra KIM
1
;
Hyucki KWON
;
Ji Hyun KIM
;
Sung Hyun PARK
;
Jae Hoon JEONG
;
Jin Seon JEONG
;
Ki Won MOON
Author Information
1. Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea. kiwonmoon@kangwon.ac.kr
- Publication Type:Case Report
- Keywords:
Myelitis, Transverse;
Rheumatoid arthritis;
Immunoglobulin
- MeSH:
Aged;
Arthritis, Rheumatoid*;
Demyelinating Diseases;
Female;
Heart Failure;
Humans;
Immunoglobulins*;
Immunoglobulins, Intravenous;
Lower Extremity;
Myelitis, Transverse*;
Paresis;
Peptic Ulcer;
Spinal Cord
- From:Korean Journal of Medicine
2015;89(5):604-608
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Acute transverse myelitis (ATM) is a heterogeneous syndrome characterized by acute spinal cord dysfunction resulting in paresis and sensory and autonomic impairment below the level of the lesion. The etiology of ATM includes parainfectious, paraneoplastic, drug-induced, systemic autoimmune disorders, and acquired demyelinating diseases. ATM is very rare in patients with rheumatoid arthritis (RA). A 79-year-old woman with RA, a recurring peptic ulcer, and congestive heart failure presented with acute weakness of both upper and lower extremities. She was diagnosed with ATM based on the results of laboratory and radiological tests. ATM is usually treated with high-dose glucocorticoid. However, we treated her with intravenous immunoglobulin (IVIG) considering the adverse events of high-dose glucocorticoid, and she improved. We report a case of ATM in a patient with RA successfully treated with IVIG.
